Ken Griffin's position in Gain Therapeutics is currently worth $209 Thousand. That's 0.00% of their equity portfolio (4079th largest holding). The first Gain Therapeutics trade was made in Q4 2021. Since then Ken Griffin bought shares four more times and sold shares on one occasions. The investor's estimated purchase price is $254 Thousand, resulting in a loss of 18%.